 |
|
naproxen
A propionic acid derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Naproxen inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of naproxen. Naproxen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Naprosyn | | | | Code name: | | RS-3540 | | | | Chemical structure names: | | - 6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid
- d-2-(6-Methoxy-2-naphthyl)propionic Acid
| | |
|
|
